ACTIVE LEARNING TEMPLATE: Medication
Jessica Willard
STUDENT NAME _____________________________________
aspirin (acetylsalicylic acid, Acuprin, ASA)
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
antipyretics, nonopioid analgesics // salicylates
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Produce analgesia and reduce inflammation and fever Analgesia. Reduction of inflammation.
by inhibiting the production of prostaglandins. Reduction of fever. Decreased incidence of
Decreases platelet aggregation.
transient ischemic attacks and MI
Complications Medication Administration
Prevention of Myocardial Infarction/Antiplatelet effectsPO
EENT: tinnitus. GI: GI BLEEDING, dyspepsia, epigastric distress, (Adults): 80 – 325 mgonce daily Suspected acute MI-160 mg as
nausea, abdominal pain, anorexia, hepatotoxicity, vomiting. Hemat: soon as MI is suspected.PO (Children): 3– 10 mg/kg/day given
once daily (round dose to a convenient amount).Pain/FeverPO,
anemia, hemolysis. Derm: rash, urticaria. Misc: allergic reactions Rect (Adults): 325– 1000 mg q 4– 6 hr (not to exceed 4 g/day).
Extended- releasetablets—650mgq8hror800mgq12hr.PO, Rect
including ANAPHYLAXIS and LARYNGEAL EDEMA. (Children 2 – 11 yr): 10 – 15 mg/kg/dose q 4 – 6 hr; maximum
dose: 4 g/ day.InflammationPO (Adults): 2.4 g/day initially;
increased to maintenance dose of 3.6 – 5.4 g/day in divided
doses (up to 7.8 g/day for acute rheumatic fever).PO (Children):
60– 100 mg/kg/day in divided doses (up to 130 mg/kg/day for
acute rheumatic fever).Prevention of Transient Ischemic
AttacksPO (Adults): 50 – 325 mg once daily.
Contraindications/Precautions
Contraindicated in: Hypersensitivity to aspirin or other
salicylates; Cross-sensitivity with other NSAIDs may exist
(less with nonaspirin salicylates); Bleeding disorders or Nursing Interventions
thrombocytopenia; Pedi: May increase risk of Reye’ s Patients who have asthma, allergies, and
nasal polyps or who are allergic to
syndrome in children or adolescents with viral infections. tartrazine are at an increased risk for
developing hypersensitivity reactions.Pain:
Assess pain and limitation of movement;
note type, location, and intensity before
Interactions and at the peak (see Time/Action Profile)
after administration.Fever: Assess fever
May increase the risk of bleeding with warfarin, heparin, heparin-like and note associated signs (diaphoresis,
agents, thrombolytic agents, dipyridamole, ticlopidine, clopidogrel, tachycardia, malaise, chills
tirofiban, or eptifibatide, although these agents are frequently used
safely in combination and in sequence.Increases anticoagulant effect
and bleeding risk with arnica, chamomile, clove, feverfew, garlic,
ginger, ginkgo, Panax ginseng, and others.
Client Education
Instruct patient to take salicylates with a full glass of water and to
remain in an up- right position for 15 – 30 min after
administration.Advise patient to report tinnitus; unusual bleeding
of gums; bruising; black, tarry stools; or fever lasting longer than
Evaluation of Medication Effectiveness 3 days.Caution patient to avoid concurrent use of alcohol with
this medication to minimize possible gastric irritation; 3 or more
glasses of alcohol per day may increase risk ofGI bleeding.
Increase in BP.Increase in peripheral circulation. Increase Caution patient to avoid taking concurrently with acetaminophen
or NSAIDs for more than a few days, unless directed by health
in urine output care professional to prevent analgesic nephropathy
ACTIVE LEARNING TEMPLATES
Jessica Willard
STUDENT NAME _____________________________________
aspirin (acetylsalicylic acid, Acuprin, ASA)
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
antipyretics, nonopioid analgesics // salicylates
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Produce analgesia and reduce inflammation and fever Analgesia. Reduction of inflammation.
by inhibiting the production of prostaglandins. Reduction of fever. Decreased incidence of
Decreases platelet aggregation.
transient ischemic attacks and MI
Complications Medication Administration
Prevention of Myocardial Infarction/Antiplatelet effectsPO
EENT: tinnitus. GI: GI BLEEDING, dyspepsia, epigastric distress, (Adults): 80 – 325 mgonce daily Suspected acute MI-160 mg as
nausea, abdominal pain, anorexia, hepatotoxicity, vomiting. Hemat: soon as MI is suspected.PO (Children): 3– 10 mg/kg/day given
once daily (round dose to a convenient amount).Pain/FeverPO,
anemia, hemolysis. Derm: rash, urticaria. Misc: allergic reactions Rect (Adults): 325– 1000 mg q 4– 6 hr (not to exceed 4 g/day).
Extended- releasetablets—650mgq8hror800mgq12hr.PO, Rect
including ANAPHYLAXIS and LARYNGEAL EDEMA. (Children 2 – 11 yr): 10 – 15 mg/kg/dose q 4 – 6 hr; maximum
dose: 4 g/ day.InflammationPO (Adults): 2.4 g/day initially;
increased to maintenance dose of 3.6 – 5.4 g/day in divided
doses (up to 7.8 g/day for acute rheumatic fever).PO (Children):
60– 100 mg/kg/day in divided doses (up to 130 mg/kg/day for
acute rheumatic fever).Prevention of Transient Ischemic
AttacksPO (Adults): 50 – 325 mg once daily.
Contraindications/Precautions
Contraindicated in: Hypersensitivity to aspirin or other
salicylates; Cross-sensitivity with other NSAIDs may exist
(less with nonaspirin salicylates); Bleeding disorders or Nursing Interventions
thrombocytopenia; Pedi: May increase risk of Reye’ s Patients who have asthma, allergies, and
nasal polyps or who are allergic to
syndrome in children or adolescents with viral infections. tartrazine are at an increased risk for
developing hypersensitivity reactions.Pain:
Assess pain and limitation of movement;
note type, location, and intensity before
Interactions and at the peak (see Time/Action Profile)
after administration.Fever: Assess fever
May increase the risk of bleeding with warfarin, heparin, heparin-like and note associated signs (diaphoresis,
agents, thrombolytic agents, dipyridamole, ticlopidine, clopidogrel, tachycardia, malaise, chills
tirofiban, or eptifibatide, although these agents are frequently used
safely in combination and in sequence.Increases anticoagulant effect
and bleeding risk with arnica, chamomile, clove, feverfew, garlic,
ginger, ginkgo, Panax ginseng, and others.
Client Education
Instruct patient to take salicylates with a full glass of water and to
remain in an up- right position for 15 – 30 min after
administration.Advise patient to report tinnitus; unusual bleeding
of gums; bruising; black, tarry stools; or fever lasting longer than
Evaluation of Medication Effectiveness 3 days.Caution patient to avoid concurrent use of alcohol with
this medication to minimize possible gastric irritation; 3 or more
glasses of alcohol per day may increase risk ofGI bleeding.
Increase in BP.Increase in peripheral circulation. Increase Caution patient to avoid taking concurrently with acetaminophen
or NSAIDs for more than a few days, unless directed by health
in urine output care professional to prevent analgesic nephropathy
ACTIVE LEARNING TEMPLATES
